BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26637703)

  • 1. Checkpoint blockade in lymphoma.
    Armand P
    Hematology Am Soc Hematol Educ Program; 2015; 2015():69-73. PubMed ID: 26637703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint blockade in hematologic malignancies.
    Armand P
    Blood; 2015 May; 125(22):3393-400. PubMed ID: 25833961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint blockade in lymphoid malignancies.
    Thanarajasingam G; Thanarajasingam U; Ansell SM
    FEBS J; 2016 Jun; 283(12):2233-44. PubMed ID: 26807978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for checkpoint inhibition in hematologic malignancies.
    Atanackovic D; Luetkens T
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):198-206. PubMed ID: 29775689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas.
    Goodman A; Patel SP; Kurzrock R
    Nat Rev Clin Oncol; 2017 Apr; 14(4):203-220. PubMed ID: 27805626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Development of PD-1 Blockade in Hematologic Malignancies.
    Pianko MJ; Goldberg AD; Lesokhin AM
    Cancer J; 2018; 24(1):31-35. PubMed ID: 29360725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-Checkpoint Blockade Therapy in Lymphoma.
    Kuzume A; Chi S; Yamauchi N; Minami Y
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of immune checkpoint inhibition in malignant lymphoma.
    Hude I; Sasse S; Engert A; Bröckelmann PJ
    Haematologica; 2017 Jan; 102(1):30-42. PubMed ID: 27884973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies.
    Tsirigotis P; Savani BN; Nagler A
    Ann Med; 2016 Sep; 48(6):428-439. PubMed ID: 27224873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma.
    Tobin JWD; Bednarska K; Campbell A; Keane C
    Cells; 2021 May; 10(5):. PubMed ID: 34068762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beginning of a novel frontier: T-cell-directed immune manipulation in lymphomas.
    Kasenda B; Kühnl A; Chau I
    Expert Rev Hematol; 2016; 9(2):123-35. PubMed ID: 26581237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking tumor escape in hematologic malignancies: the anti-PD-1 strategy.
    Bryan LJ; Gordon LI
    Blood Rev; 2015 Jan; 29(1):25-32. PubMed ID: 25260226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programming the immune checkpoint to treat hematologic malignancies.
    Vick E; Mahadevan D
    Expert Opin Investig Drugs; 2016 Jul; 25(7):755-70. PubMed ID: 27070269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting immune checkpoints in hematological malignancies.
    Salik B; Smyth MJ; Nakamura K
    J Hematol Oncol; 2020 Aug; 13(1):111. PubMed ID: 32787882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-Checkpoint Inhibitors in B-Cell Lymphoma.
    Armengol M; Santos JC; Fernández-Serrano M; Profitós-Pelejà N; Ribeiro ML; Roué G
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint inhibition in lymphoid disease.
    Eyre TA; Collins GP
    Br J Haematol; 2015 Aug; 170(3):291-304. PubMed ID: 25824455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant.
    Merryman RW; Armand P
    Curr Hematol Malig Rep; 2017 Feb; 12(1):44-50. PubMed ID: 28155012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1 /PD-L1 checkpoint in hematological malignancies.
    Annibali O; Crescenzi A; Tomarchio V; Pagano A; Bianchi A; Grifoni A; Avvisati G
    Leuk Res; 2018 Apr; 67():45-55. PubMed ID: 29428449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of Lymphoma and Myeloma: Facts and Hopes.
    Pianko MJ; Moskowitz AJ; Lesokhin AM
    Clin Cancer Res; 2018 Mar; 24(5):1002-1010. PubMed ID: 28899972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.
    Michot JM; Lazarovici J; Ghez D; Danu A; Fermé C; Bigorgne A; Ribrag V; Marabelle A; Aspeslagh S
    Eur J Cancer; 2017 Nov; 85():67-77. PubMed ID: 28892775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.